While the song’s backstory might be staged on its cover - a recreation of the moment Harry Houdini was supposedly passed a ...

John Stoltzfus, Oppenheimer chief investment strategist, joins CNBC's 'Squawk on the Street' to discuss how market could ...

Fintel reports that on July 7, 2025, Oppenheimer initiated coverage of Pulse Biosciences (NasdaqCM:PLSE) with a Outperform recommendation. Analyst Price Forecast Suggests 74.21% Downside As of March ...

James Cameron recently called out Christopher Nolan’s Oscar-winning film “Oppenheimer” for being “a moral cop out” in the ...

A Los Alamos home was featured in one of the biggest summer blockbusters. Now, a group is trying to open it up for the public ...

Mission: Impossible - The Final Reckoning's next target is Aquaman 2's box office haul in China. Read on for more.

U.S. men's tennis star Ben Shelton is on the verge of a big win in the second round of Wimbledon on Thursday. While Shelton ...

The Thomas Crown Affair' has added Kenneth Branagh to its cast, bringing aboard Oscar winner Charles Roven to produce.

James Cameron has hit out at rival director Christopher Nolan ’s Oscar-winning film Oppenheimer, calling it a “moral cop-out” ...

Sound Point Meridian Capital, Inc. (the "Company") (NYSE: SPMC), an externally managed closed-end fund focused on primarily investing in equity and junior debt tranches of collateralized loan ...

Avatar director James Cameron has said Christopher Nolan’s Oppenheimer was “a bit of a moral cop out,” while revealing his ...

Revolution Medicines, Inc. (NASDAQ:RVMD) ranks among the 30 stocks expected to beat the market by 20 percentage points this ...